|Articles|May 21, 2019
I-ACT for Children Selects Advarra as Central IRB
Advertisement
Advarra has announced that it has been selected by the Institute for Advanced Clinical Trials for Children to provide central institutional review board services to the organization’s pediatric clinical trial site network. I-ACT for Children currently includes 44 U.S. pediatric research sites.
For further details, click here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMGSeptember 15th 2025
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
